Abstract:Breast cancer is one of the leading causes of death among women in the US, and early diagnosis of the disease contributes significantly to the survival rates of patients. Metabolomics data, which can be obtained in a non-invasive manner through blood plasma sampling, coupled with machine learning methods, has been increasingly applied to the field of biology, opening up a novel dimension of quantitative analysis that has the potential to unlock the secrets to highly complex diseases such as cancer. In this study, machine learning methods were leveraged to analyze several hundred metabolomic signatures of breast cancer patients towards discrimination between malignant and benign tumors. Samples of plasma were taken from 100 female breast cancer patients (50 from malignant and 50 from benign tumors) and metabolite molecules such as lipids and bile acids were extracted using ultra-performance liquid chromatography coupled with tandem mass spectrometry. The data were then log-transformed, and metabolites with a significant log-fold-change were selected for dimensionality reduction using a Wilcoxon test. These data where then analyzed using an ensemble of 8 different models: decision tree, gradient boosting, random forest, elastic net, linear discriminant analysis, support vector machine, nearest shrunken centroids, and a neural network. The accuracy was evaluated using the ROC cuve and AUC. Variations on these models were included in analysis, including principal component transformations. The most successful model was built using recursive feature selection and a logistic regression model with L1 regularization, which had an accuracy score of 95.0% and a biomarker panel of 42 assembled metabolites from the original 358. With the Wilcoxon-selected feature set of 62 metabolites, gradient boosting and random forest algorithms also returned accuracy scores of up to 90% and with an AUC of 0.98. Future refinements on these models could eventually lead to the use of the biomarkers in a clinical setting, helping to improve survival rates through early detection of malignant breast cancer tumors.

Discriminant Analysis Based on Wavelet Transform in Metabolomics Liquid Chromatography Data

Screening and Bioinformatics Analysis of Lung Cancer Exhale Breath Biomarkers

Wavelet Transform and Bagging Predictor Approaches to Cancer Identification from Mass Spectrometry-Based Proteomic Data

A Method for Handling Metabonomics Data from Liquid Chromatography/mass Spectrometry: Combinational Use of Support Vector Machine Recursive Feature Elimination, Genetic Algorithm and Random Forest for Feature Selection

Wavelet feature extraction and genetic algorithm for biomarker detection in colorectal cancer data

A wavelet-based data pre-processing analysis approach in mass spectrometry.

Wavelet-Based Classification and Influence Matrix Analysis Method for the Fast Discrimination of Chinese Herbal Medicines According to the Geographical Origins with Near Infrared Spectroscopy

Machine Learning and Metabolomics: Diagnosis of Malignant Breast Cancer

The Weight-Based Feature Selection (WBFS) Algorithm Classifies Lung Cancer Subtypes Using Proteomic Data

Diagnosis of breast cancer using HPLC metabonomics fingerprints coupled with computational methods.

Study on chromatographic data pre-processing using fuzzy decision making in metabonomics.

Early detection of ovarian cancer by wavelet analysis of protein mass spectra

Preprocessing and Classifying of Mass Spectrometry-Based Proteomics Data Using Wavelet Transform and Decision Tree Learning

Discrimination Analysis of Mass Spectrometry Proteomics for Ovarian Cancer Detection

Random Forest In Clinical Metabolomics For Phenotypic Discrimination And Biomarker Selection

Feature Extraction and Classification of Tumor Based on Wavelet Package and Support Vector Machines

Feature Extraction and Classification of Proteomics Data Using Stationary Wavelet Transform and Naive Bayes Classifier

Weighted Variable Kernel Support Vector Machine Classifier for Metabolomics Data Analysis

Ultra-High Performance Liquid Chromatography–Mass Spectrometry for the Metabolomic Analysis of Urine in Colorectal Cancer

Ovarian Cancer Diagnostics using Wavelet Packet Scaling Descriptors

Pure Ion Chromatograms Combined with Advanced Machine Learning Methods Improve Accuracy of Discriminant Models in LC–MS-Based Untargeted Metabolomics